InvestorsHub Logo
Followers 14
Posts 2972
Boards Moderated 0
Alias Born 07/19/2006

Re: marthambles post# 10059

Saturday, 04/25/2015 10:35:21 AM

Saturday, April 25, 2015 10:35:21 AM

Post# of 29432
Dr. Oz: His tidbit on GMO's:

Dr. Mehmet Oz April 23, 2015

http://time.com/3831926/dr-oz-criticism-answers/?xid=newsletter-brief

Other times the topics are controversial, but are still worthwhile, like our campaign supporting GMO labeling. And this brings me back to a motive for the letter. These doctors criticized my “baseless and relentless opposition to the genetic engineering of food crops,” which is another false accusation. Whether you support genetically engineered crops or not, the freedom to make an informed choice should belong to consumers. The bill in Congress this month proposing to block states from independently requiring labeling offers a coup to pro-GMO groups.

As a scientist, I am not that concerned about GMOs themselves, but I am worried about why they were created. Highly toxic herbicides would kill crops unless they were genetically modified, but with the genetic upgrade, these plants can be doused with much higher doses, with potential complications to the environment. The WHO believes that glyphosate is “probably a human carcinogen.” Perhaps we are all showing “disdain for science and evidence-based medicine,” but I would argue that unleashing these products creates a real-time experiment on the human species. Sure, we will eventually know if these pesticides are a problem, but at the expense of the pain and suffering and disease in real people. I owe my kids more. And so do you.


Messages posted by individuals may be misleading, deceptive, or in error. If you disagree with a posting, feel free to voice your opinion. It is the policy of iHub to allow our members to freely discuss issues in a free and open manner

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.